100 related articles for article (PubMed ID: 15868437)
21. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
[TBL] [Abstract][Full Text] [Related]
23. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
24. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA
Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850
[TBL] [Abstract][Full Text] [Related]
26. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
27. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
28. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
30. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.
Li Y; Wei Q; Cao F; Cao X
Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370
[TBL] [Abstract][Full Text] [Related]
31. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
[TBL] [Abstract][Full Text] [Related]
32. Abnormal expression of period 1 (PER1) in endometrial carcinoma.
Yeh KT; Yang MY; Liu TC; Chen JC; Chan WL; Lin SF; Chang JG
J Pathol; 2005 May; 206(1):111-20. PubMed ID: 15809976
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
38. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.
Zeller C; Hinzmann B; Seitz S; Prokoph H; Burkhard-Goettges E; Fischer J; Jandrig B; Schwarz LE; Rosenthal A; Scherneck S
Oncogene; 2003 May; 22(19):2972-83. PubMed ID: 12771949
[TBL] [Abstract][Full Text] [Related]
39. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
40. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer.
Chen C; Bhalala HV; Qiao H; Dong JT
Oncogene; 2002 Sep; 21(43):6567-72. PubMed ID: 12242654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
